Clinical Trials
Explore eczema clinical trials across Australia and help shape the future of treatment.
Clinical trials play a vital role in improving eczema treatments and deepening our understanding of the condition. On this page, you'll find information about eczema-related clinical trials happening across Australia, including how to participate, what to expect, and who might be eligible. Whether you're considering taking part or simply want to stay informed, we're here to guide you every step of the way and help you make confident, informed decisions about your eczema care.
Atopic Dermatitis Study
TRex Bio
Help us find a new approach to treat atopic dermatitis (eczema)
Consider taking part in a clinical study of an investigational drug for atopic dermatitis (AD)
In atopic dermatitis inflammation (swelling) is triggered when an overactive immune (body’s defence) system damages skin-barrier tissue. Laboratory studies have shown that this investigational drug (study drug) could possibly decrease inflammation and help with tissue repair in AD.
This study is to see if the investigational medication is safe and can improve AD and make you feel better.
You may be able to take part in this study if you:
· Are aged between 18 – 70 years of age
· Have moderate to severe atopic dermatitis for at least 1 year
If you take part, you will receive either the investigational drug or placebo - a placebo is a solution without any active ingredients that looks the same as the investigational drug.
You will receive 4 doses of study drug or placebo which will be administered every 4 weeks as a subcutaneous (under the skin) injection over 12 weeks. The study will last for 8-9 months and will include up to 15 visits to the clinic after the screening period.
Participants are reimbursed for their time and travel expenses.
How do I get more information?
Get the ongoing support you need and deserve
Don't let eczema hold you back - invest in your well-being and embrace a brighter tomorrow with our yearly membership.